Regulus Therapeutics Inc. (RGLS) News Nov 20, 2014
Post# of 250601
Posted On: 11/21/2014 5:21:46 AM
Regulus Therapeutics Inc. (RGLS) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on RGLS
6 stocks to watch 3:06 p.m. Nov. 5, 2014 - The Trading Deck
Berkshire investment boost, new CFO give a lift to DaVita shares 10:17 a.m. July 8, 2013 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 3:24 p.m. Oct. 4, 2012 - MarketWatch
Other News on RGLS
Regulus To See Further Declines 10:30 a.m. Nov. 19, 2014 - Seeking Alpha
Strong On High Relative Volume: Regulus Therapeutics (RGLS) 10:01 a.m. Nov. 18, 2014 - TheStreet.com
Regulus Therapeutics' (RGLS) CEO Kleanthis Xanthopoulos Presents at Credit Suisse 2014 Healthcare Conference (Transcript) 8:15 p.m. Nov. 12, 2014 - Seeking Alpha
Gilead presents Harvoni data 11:03 a.m. Nov. 11, 2014 - Seeking Alpha
AbbVie presents HCV/HIV and liver transplant HCV data 10:07 a.m. Nov. 11, 2014 - Seeking Alpha
Merck presents data from its investigational HCV combo 9:37 a.m. Nov. 11, 2014 - Seeking Alpha
Gilead presents data from three HCV drug combo studies 9:05 a.m. Nov. 11, 2014 - Seeking Alpha
Regulus Slumps: RGLS Falls 5.3% in Session - Tale of the Tape 8:53 a.m. Nov. 11, 2014 - Zacks.com
Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting 10:40 a.m. Nov. 10, 2014 - TheStreet.com
Regulus Therapeutics (RGLS) Strong On High Relative Volume Today 10:04 a.m. Nov. 10, 2014 - TheStreet.com
Merck triple therapy HCV candidate fails as a four-week regimen 7:49 a.m. Nov. 10, 2014 - Seeking Alpha
Bristol-Myers presents data on HCV Trio regimen 6:04 p.m. Nov. 9, 2014 - Seeking Alpha
Bristol-Myers presents data on shorter regimen HCV drug combo 5:37 p.m. Nov. 9, 2014 - Seeking Alpha
Achillion presents HCV data at The Liver Meeting 5:06 p.m. Nov. 9, 2014 - Seeking Alpha
Trade-Ideas: Regulus Therapeutics (RGLS) Is Today's Post-Market Leader Stock 5:13 p.m. Nov. 7, 2014 - TheStreet.com
Insider Trading Alert - CBG, RGLS And WAB Traded By Insiders 11:45 a.m. Nov. 6, 2014 - TheStreet.com
Regulus Therapeutics (RGLS) is in Overbought Territory: What's Next? - Tale of the Tape 9:12 a.m. Nov. 6, 2014 - Zacks.com
10-Q: REGULUS THERAPEUTICS INC. 6:10 a.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Regulus Therapeutic's (RGLS) CEO Kleanthis Xanthopoulos on Q3 2014 Results -- Earnings Call Transcript 9:18 p.m. Nov. 5, 2014 - Seeking Alpha
Regulus Therapeutics (RGLS) Q3 2014 Results - Earnings Call Webcast 4:55 p.m. Nov. 5, 2014 - Seeking Alpha
Press Releases on RGLS
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
DexCom Announces Appointment of Mark G. Foletta as Board Member 8:31 a.m. Nov. 19, 2014 - BusinessWire - BZX
Critical Alerts For Zillow, Organovo, Regulus Therapeutics, JC Penney and FireEye Released By InvestorsObserver 9:31 a.m. Nov. 17, 2014 - PR Newswire - PRF
Regulus and Sanofi Present New Data Enhancing the Preclinical Profile of RG-012, an Anti-miR Targeting microRNA-21 for the Treatment of Renal Dysfunction in Alport Syndrome Patients, at ASN's Kidney Week 2014 Meeting 6:00 p.m. Nov. 15, 2014 - PR Newswire - PRF
Regulus to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Regulus Reports Third Quarter 2014 Financial Results and Recent Highlights 4:05 p.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call 3:05 p.m. Oct. 30, 2014 - PR Newswire - PRF
Regulus Announces Pricing of Public Offering of Common Stock 7:10 p.m. Oct. 28, 2014 - PR Newswire - PRF
Financial Results, Dividends, Positive Study Results, and Upcoming Earnings Releases - Research Reports on Varian Medical, Regulus, Cummins, AEP and NextEra 7:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
Regulus Announces Commencement of Public Offering of Common Stock 3:00 p.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Regulus Therapeutics, iRobot, Nike and Twitter Released By InvestorsObserver 8:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, 3D Systems, Regulus Therapeutics, Huntington Bancshares, Cree, and AMD 7:45 a.m. Oct. 23, 2014 - PR Newswire - PRF
A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment History 6:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Regulus Presents New Preclinical Data on Multiple Programs and Provides Portfolio Overview at 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 7:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Regulus Announces Notice of Allowance from U.S. Patent Office Related to microRNA-103/107 Program in Metabolic Disorders 7:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 7:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 12:22 p.m. Aug. 19, 2014 - PR Newswire - PRF
Regulus to Present at the Wedbush Life Sciences Management Access Conference 3:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 7:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
MarketWatch News on RGLS
6 stocks to watch 3:06 p.m. Nov. 5, 2014 - The Trading Deck
Berkshire investment boost, new CFO give a lift to DaVita shares 10:17 a.m. July 8, 2013 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 3:24 p.m. Oct. 4, 2012 - MarketWatch
Other News on RGLS
Regulus To See Further Declines 10:30 a.m. Nov. 19, 2014 - Seeking Alpha
Strong On High Relative Volume: Regulus Therapeutics (RGLS) 10:01 a.m. Nov. 18, 2014 - TheStreet.com
Regulus Therapeutics' (RGLS) CEO Kleanthis Xanthopoulos Presents at Credit Suisse 2014 Healthcare Conference (Transcript) 8:15 p.m. Nov. 12, 2014 - Seeking Alpha
Gilead presents Harvoni data 11:03 a.m. Nov. 11, 2014 - Seeking Alpha
AbbVie presents HCV/HIV and liver transplant HCV data 10:07 a.m. Nov. 11, 2014 - Seeking Alpha
Merck presents data from its investigational HCV combo 9:37 a.m. Nov. 11, 2014 - Seeking Alpha
Gilead presents data from three HCV drug combo studies 9:05 a.m. Nov. 11, 2014 - Seeking Alpha
Regulus Slumps: RGLS Falls 5.3% in Session - Tale of the Tape 8:53 a.m. Nov. 11, 2014 - Zacks.com
Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting 10:40 a.m. Nov. 10, 2014 - TheStreet.com
Regulus Therapeutics (RGLS) Strong On High Relative Volume Today 10:04 a.m. Nov. 10, 2014 - TheStreet.com
Merck triple therapy HCV candidate fails as a four-week regimen 7:49 a.m. Nov. 10, 2014 - Seeking Alpha
Bristol-Myers presents data on HCV Trio regimen 6:04 p.m. Nov. 9, 2014 - Seeking Alpha
Bristol-Myers presents data on shorter regimen HCV drug combo 5:37 p.m. Nov. 9, 2014 - Seeking Alpha
Achillion presents HCV data at The Liver Meeting 5:06 p.m. Nov. 9, 2014 - Seeking Alpha
Trade-Ideas: Regulus Therapeutics (RGLS) Is Today's Post-Market Leader Stock 5:13 p.m. Nov. 7, 2014 - TheStreet.com
Insider Trading Alert - CBG, RGLS And WAB Traded By Insiders 11:45 a.m. Nov. 6, 2014 - TheStreet.com
Regulus Therapeutics (RGLS) is in Overbought Territory: What's Next? - Tale of the Tape 9:12 a.m. Nov. 6, 2014 - Zacks.com
10-Q: REGULUS THERAPEUTICS INC. 6:10 a.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Regulus Therapeutic's (RGLS) CEO Kleanthis Xanthopoulos on Q3 2014 Results -- Earnings Call Transcript 9:18 p.m. Nov. 5, 2014 - Seeking Alpha
Regulus Therapeutics (RGLS) Q3 2014 Results - Earnings Call Webcast 4:55 p.m. Nov. 5, 2014 - Seeking Alpha
Press Releases on RGLS
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
DexCom Announces Appointment of Mark G. Foletta as Board Member 8:31 a.m. Nov. 19, 2014 - BusinessWire - BZX
Critical Alerts For Zillow, Organovo, Regulus Therapeutics, JC Penney and FireEye Released By InvestorsObserver 9:31 a.m. Nov. 17, 2014 - PR Newswire - PRF
Regulus and Sanofi Present New Data Enhancing the Preclinical Profile of RG-012, an Anti-miR Targeting microRNA-21 for the Treatment of Renal Dysfunction in Alport Syndrome Patients, at ASN's Kidney Week 2014 Meeting 6:00 p.m. Nov. 15, 2014 - PR Newswire - PRF
Regulus to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Regulus Reports Third Quarter 2014 Financial Results and Recent Highlights 4:05 p.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call 3:05 p.m. Oct. 30, 2014 - PR Newswire - PRF
Regulus Announces Pricing of Public Offering of Common Stock 7:10 p.m. Oct. 28, 2014 - PR Newswire - PRF
Financial Results, Dividends, Positive Study Results, and Upcoming Earnings Releases - Research Reports on Varian Medical, Regulus, Cummins, AEP and NextEra 7:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
Regulus Announces Commencement of Public Offering of Common Stock 3:00 p.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Regulus Therapeutics, iRobot, Nike and Twitter Released By InvestorsObserver 8:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, 3D Systems, Regulus Therapeutics, Huntington Bancshares, Cree, and AMD 7:45 a.m. Oct. 23, 2014 - PR Newswire - PRF
A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment History 6:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Regulus Presents New Preclinical Data on Multiple Programs and Provides Portfolio Overview at 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 7:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Regulus Announces Notice of Allowance from U.S. Patent Office Related to microRNA-103/107 Program in Metabolic Disorders 7:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 7:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 12:22 p.m. Aug. 19, 2014 - PR Newswire - PRF
Regulus to Present at the Wedbush Life Sciences Management Access Conference 3:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 7:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼